Kim Huynh-Ba
Editor

2009

Regulations, Methodologies,
and Best Practices

In my professional career as a pharmaceutical scientist, I have been involved with several aspects of the drug development process from pre-IND to commercialization and, somehow, I usually found myself coming back to a stability-related issue. The stability area seemed to draw my utmost interest because in my day-to-day work, my opportunities involved more than one product, and none of the issues were the same.